PetMed Express, Inc. (PETS)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$2.27
-1.31%
Mkt Cap $55.43M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$11.00
Range $7.00 – $19.00
Implied Upside
+384.6%
Consensus $11.00 vs current $2.27